The Ludwig Boltzmann Institute Applied Diagnostics (lbi:ad) was a translational research institution of the Ludwig Boltzmann Gesellschaft with the aim of combining a team of transdisciplinary scientists, academic and industrial partners from several countries.

We followed a new dual biomarker concept for tumor diagnosis. The focus of the institute lied on the development of minimal-invasive diagnostic methods linking molecular epigenetic and genetic signatures with molecular imaging biomarkers for PET and SPECT analysis. The combination of these two methods allows for improved functional, spatial and temporal assessment of tumor load and molecular tumor characterization.